Systemic Lupus Erythematosus (SLE) Therapy: The Old and the New
Abstract Despite recent improvements in the treatment of systemic lupus erythematosus (SLE), disease activity, comorbidities and drug toxicity significantly contribute to the risk of progressive irreversible damage accrual and increased mortality in patients with this chronic disease. Moreover, even...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Adis, Springer Healthcare
2020-06-01
|
Series: | Rheumatology and Therapy |
Subjects: | |
Online Access: | https://doi.org/10.1007/s40744-020-00212-9 |